Rivastigmine in the Treatment of Dementia Associated with Parkinson's Disease: A Randomized, Double-blind, Placebo-controlled Study
Progress in Neurotherapeutics and Neuropsychopharmacology · 2006
DOI: 10.1017/s1748232105000030 ↗Kurz gefasst
Fachartikel in der Zeitschrift Progress in Neurotherapeutics and Neuropsychopharmacology, 2006. Verfasst von Sibel Tekin und 1 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Tekin, S., & Lane, R. (2006). Rivastigmine in the Treatment of Dementia Associated with Parkinson's Disease: A Randomized, Double-blind, Placebo-controlled Study. Progress in Neurotherapeutics and Neuropsychopharmacology. https://doi.org/10.1017/s1748232105000030
Vancouver
Tekin S, Lane R. Rivastigmine in the Treatment of Dementia Associated with Parkinson's Disease: A Randomized, Double-blind, Placebo-controlled Study. Progress in Neurotherapeutics and Neuropsychopharmacology. 2006. doi:10.1017/s1748232105000030
BibTeX
@article{Tekin2006,
author = {Tekin, Sibel and Lane, Roger},
title = {Rivastigmine in the Treatment of Dementia Associated with Parkinson's Disease: A Randomized, Double-blind, Placebo-controlled Study},
journal = {Progress in Neurotherapeutics and Neuropsychopharmacology},
year = {2006},
doi = {10.1017/s1748232105000030}
}
EUVIMED